<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7194797\results\search\disease\results.xml">
  <result pre=": bold;} span.year {font-family : courier ; font-style : italic;}" exact="Diabetes" post="Metab SyndrDiabetes Metab SyndrDiabetes &amp;amp; Metabolic Syndrome1871-40211878-0334Diabetes India. Published"/>
  <result pre="âˆ—Corresponding author. draksingh_2001@yahoo.com pmc-release: 2020-4-4ppub: 2020epub: 2020-4-4144277281received: 2020-4-3rev-recd: 2020-4-7accepted: 2020-4-8(C)" exact="Diabetes" post="India, 2020Since January 2020 Elsevier has created a COVID-19"/>
  <result pre="- including this research content - immediately available in PubMed" exact="Central" post="and other publicly funded repositories, such as the WHO"/>
  <result pre="different coronaviruses in the different parts of the world namely;" exact="Severe" post="acute respiratory syndrome cornonavirus-1 (SARS-CoV-1), Middle East respiratory syndrome"/>
  <result pre="coronaviruses in the different parts of the world namely; Severe" exact="acute" post="respiratory syndrome cornonavirus-1 (SARS-CoV-1), Middle East respiratory syndrome (MERS-CoV)"/>
  <result pre="in the different parts of the world namely; Severe acute" exact="respiratory" post="syndrome cornonavirus-1 (SARS-CoV-1), Middle East respiratory syndrome (MERS-CoV) and"/>
  <result pre="the different parts of the world namely; Severe acute respiratory" exact="syndrome" post="cornonavirus-1 (SARS-CoV-1), Middle East respiratory syndrome (MERS-CoV) and Severe"/>
  <result pre="world namely; Severe acute respiratory syndrome cornonavirus-1 (SARS-CoV-1), Middle East" exact="respiratory" post="syndrome (MERS-CoV) and Severe acute respiratory syndrome cornonavirus-2 (SARS-CoV-2)."/>
  <result pre="namely; Severe acute respiratory syndrome cornonavirus-1 (SARS-CoV-1), Middle East respiratory" exact="syndrome" post="(MERS-CoV) and Severe acute respiratory syndrome cornonavirus-2 (SARS-CoV-2). We"/>
  <result pre="respiratory syndrome cornonavirus-1 (SARS-CoV-1), Middle East respiratory syndrome (MERS-CoV) and" exact="Severe" post="acute respiratory syndrome cornonavirus-2 (SARS-CoV-2). We aimed to delineate"/>
  <result pre="syndrome cornonavirus-1 (SARS-CoV-1), Middle East respiratory syndrome (MERS-CoV) and Severe" exact="acute" post="respiratory syndrome cornonavirus-2 (SARS-CoV-2). We aimed to delineate the"/>
  <result pre="cornonavirus-1 (SARS-CoV-1), Middle East respiratory syndrome (MERS-CoV) and Severe acute" exact="respiratory" post="syndrome cornonavirus-2 (SARS-CoV-2). We aimed to delineate the differences"/>
  <result pre="(SARS-CoV-1), Middle East respiratory syndrome (MERS-CoV) and Severe acute respiratory" exact="syndrome" post="cornonavirus-2 (SARS-CoV-2). We aimed to delineate the differences in"/>
  <result pre="syndrome cornonavirus-2 (SARS-CoV-2). We aimed to delineate the differences in" exact="viral" post="dynamics and clinical features between them and tried to"/>
  <result pre="the articles published on SARS-CoV-2, SARS-CoV-1, MERS-CoV that dealt with" exact="viral" post="dynamics. Results Ample data is available to suggest the"/>
  <result pre="SARS-CoV-1, MERS-CoV and SARS-CoV-2. Conclusion Although SARS-CoV-2 (COVID-19) is more" exact="infectious" post="than SARS-CoV-1 and MERS-CoV, most infections are generally mild"/>
  <result pre="SARS-CoV-2 (COVID-19) is more infectious than SARS-CoV-1 and MERS-CoV, most" exact="infections" post="are generally mild and self-limiting. However, case-fatality rates are"/>
  <result pre="is more infectious, has a long incubation period and a" exact="short" post="serial interval but low case-fatality rate than SARS-CoV-1 and"/>
  <result pre="of prevention from contracting COVID-19. Keywords SARS-CoV-1 SARS-Co-V-2 MERS COVID-19" exact="Viral" post="dynamics 1 Introduction Viral diseases continue to pose a"/>
  <result pre="COVID-19. Keywords SARS-CoV-1 SARS-Co-V-2 MERS COVID-19 Viral dynamics 1 Introduction" exact="Viral" post="diseases continue to pose a serious threat to public"/>
  <result pre="serious threat to public health. The world has witnessed several" exact="viral" post="epidemics in past twenty years that include severe acute"/>
  <result pre="several viral epidemics in past twenty years that include severe" exact="acute" post="respiratory syndrome coronavirus (SARS-CoV-1) in 2003, H1N1 influenza in"/>
  <result pre="viral epidemics in past twenty years that include severe acute" exact="respiratory" post="syndrome coronavirus (SARS-CoV-1) in 2003, H1N1 influenza in 2009"/>
  <result pre="epidemics in past twenty years that include severe acute respiratory" exact="syndrome" post="coronavirus (SARS-CoV-1) in 2003, H1N1 influenza in 2009 and"/>
  <result pre="in 2003, H1N1 influenza in 2009 and the Middle East" exact="respiratory" post="syndrome coronavirus (MERS-CoV) in 2012. Recently, an outbreak of"/>
  <result pre="2003, H1N1 influenza in 2009 and the Middle East respiratory" exact="syndrome" post="coronavirus (MERS-CoV) in 2012. Recently, an outbreak of pneumonia"/>
  <result pre="respiratory syndrome coronavirus (MERS-CoV) in 2012. Recently, an outbreak of" exact="pneumonia" post="of unknown etiology was detected in Wuhan City, Hubei"/>
  <result pre="seafood market in Wuhan City. The etiological agent of the" exact="atypical pneumonia" post="was isolated on January 7, 2020 by the Chinese"/>
  <result pre="market in Wuhan City. The etiological agent of the atypical" exact="pneumonia" post="was isolated on January 7, 2020 by the Chinese"/>
  <result pre="SARS. On February 11, 2020, the WHO announced that the" exact="disease" post="caused by this new virus as a &quot;COVID-19,&quot; which"/>
  <result pre="virus as a &quot;COVID-19,&quot; which is the acronym of &quot;coronavirus" exact="disease" post="2019&quot;. On March 11, 2020, WHO declared this disease"/>
  <result pre="&quot;coronavirus disease 2019&quot;. On March 11, 2020, WHO declared this" exact="disease" post="as pandemic. As of March 30, 2020, WHO has"/>
  <result pre="(such as HCoV-229E and HCoV-NL63), causes common colds and self-limiting" exact="respiratory" post="infections. In contrast, B lineage of beta-corona virus causes"/>
  <result pre="responsible for recent epidemics with a variable clinical severity of" exact="pulmonary" post="and extra-pulmonary involvement and associated significant increase in mortality"/>
  <result pre="however, some of the studies suggests pangolin could be the" exact="intermediate" post="mammalian hosts. Since spike protein of SAR-CoV-2 are nearly"/>
  <result pre="pangolin, it is believed that pangolins could have provided a" exact="partial" post="spike gene to SARS-CoV-2, to infect mammals [10,11]. A"/>
  <result pre="infected, virus could also be transmitted from human-to-human through the" exact="respiratory" post="droplets and aerosols from coughing and sneezing, like other"/>
  <result pre="respiratory droplets and aerosols from coughing and sneezing, like other" exact="respiratory" post="pathogens, including SARS-CoV-2. SARS-CoV-2 also uses the angiotensin converting"/>
  <result pre="on the data from Chinese CDC. The longest time from" exact="infection" post="to symptoms was 12.5 days (95% CI, 9.2â€&quot;18 days)."/>
  <result pre="every seven days and on average, each patient transmits the" exact="infection" post="to an additional 2.2 individuals, suggesting the basic reproduction"/>
  <result pre="MERS-CoV Origin Wuhan, China Guangdong, China Jeddah, Saudi Arab Asymptomatic" exact="viral" post="load High Less Less Long period of infectivity Yes"/>
  <result pre="Host Pangolin Civet Camel Terminal Host Humans Humans Humans Transmission" exact="Respiratory" post="droplets Yes Yes Yes Fomites, Contact Yes No No"/>
  <result pre="Yes Yes Yes Fomites, Contact Yes No No Zoonotic Yes" exact="Sporadic" post="Sporadic Aerosol High Possibility Yes Yes Feco-Oral High Possibility"/>
  <result pre="Yes Yes Fomites, Contact Yes No No Zoonotic Yes Sporadic" exact="Sporadic" post="Aerosol High Possibility Yes Yes Feco-Oral High Possibility Yes"/>
  <result pre="Feco-Oral High Possibility Yes No Human to human Yes Yes" exact="Limited" post="Nosocomial Yes Yes Yes Cell entry receptor ACE2 ACE2"/>
  <result pre="a relatively weaker selective pressure [13]. These ultra-rapid development in" exact="viral" post="epidemics strongly suggest an urgent need of understanding about"/>
  <result pre="epidemics strongly suggest an urgent need of understanding about these" exact="viral" post="dynamics to cope up with this public health emergency"/>
  <result pre="It may be classified as asymptomatic or symptomatic, carrier or" exact="infective" post="state, from mild prodrome to profusely symptomatic; depending upon"/>
  <result pre="male sex, smokers and associated comorbidities including obesity, hypertension, diabetes," exact="chronic" post="pulmonary diseases, cardiovascular disease and chronic kidney disease. More"/>
  <result pre="sex, smokers and associated comorbidities including obesity, hypertension, diabetes, chronic" exact="pulmonary" post="diseases, cardiovascular disease and chronic kidney disease. More the"/>
  <result pre="and associated comorbidities including obesity, hypertension, diabetes, chronic pulmonary diseases," exact="cardiovascular disease" post="and chronic kidney disease. More the number of risk"/>
  <result pre="associated comorbidities including obesity, hypertension, diabetes, chronic pulmonary diseases, cardiovascular" exact="disease" post="and chronic kidney disease. More the number of risk"/>
  <result pre="including obesity, hypertension, diabetes, chronic pulmonary diseases, cardiovascular disease and" exact="chronic" post="kidney disease. More the number of risk factors, more"/>
  <result pre="obesity, hypertension, diabetes, chronic pulmonary diseases, cardiovascular disease and chronic" exact="kidney disease." post="More the number of risk factors, more is the"/>
  <result pre="divided as mild, moderate, severe and critical [18]. a.Mild COVID-19:" exact="low grade" post="fever, cough, malaise, rhinorrhea, sore throat with or without"/>
  <result pre="hemoptysis, nausea, vomiting, diarrhea, but without any radiological features of" exact="pneumonia" post="and absence of mental changes. b.Moderate COVID-19: fever, respiratory"/>
  <result pre="vomiting, diarrhea, but without any radiological features of pneumonia and" exact="absence of" post="mental changes. b.Moderate COVID-19: fever, respiratory symptoms including dry"/>
  <result pre="of pneumonia and absence of mental changes. b.Moderate COVID-19: fever," exact="respiratory" post="symptoms including dry cough and shortness of breath that"/>
  <result pre="emerge along with the radiological features [15]. c.Severe COVID-19: dyspnea," exact="respiratory" post="frequency â‰¥30/minute, blood oxygen saturation â‰¤93%, PaO2/FiO2 ratio &amp;lt;300,"/>
  <result pre="7 days in patients with mild/moderate/severe COVID-19 with features of" exact="Acute respiratory distress syndrome" post="(ARDS) requiring mechanical ventilation along with presence of multiorgan"/>
  <result pre="days in patients with mild/moderate/severe COVID-19 with features of Acute" exact="respiratory" post="distress syndrome (ARDS) requiring mechanical ventilation along with presence"/>
  <result pre="patients with mild/moderate/severe COVID-19 with features of Acute respiratory distress" exact="syndrome" post="(ARDS) requiring mechanical ventilation along with presence of multiorgan"/>
  <result pre="requiring mechanical ventilation along with presence of multiorgan dysfunction failure," exact="metabolic acidosis" post="and coagulation dysfunction. The differences in clinical features of"/>
  <result pre="mechanical ventilation along with presence of multiorgan dysfunction failure, metabolic" exact="acidosis" post="and coagulation dysfunction. The differences in clinical features of"/>
  <result pre="SARS-CoV-1 MERS-CoV Mild 80% 61% 21% Severe/Critical 14â€&quot;15%/4â€&quot;5% 11% 46%" exact="Fever" post="Yes, Mild Yes Yes Chills No Yes Yes Dry"/>
  <result pre="May be Yes May not Sputum Rare Yes May be" exact="Diarrhea" post="Less Yes Yes MOF Renal, Liver, Testes Liver Liver"/>
  <result pre="Critical ARDS ARDS ARDS, ARF MOF â€&quot; multi-organ failure, ARDS:" exact="Acute" post="Respiratory Distress Syndrome, ARF-Acute Renal Failure. 5 Laboratory findings"/>
  <result pre="ARDS ARDS ARDS, ARF MOF â€&quot; multi-organ failure, ARDS: Acute" exact="Respiratory" post="Distress Syndrome, ARF-Acute Renal Failure. 5 Laboratory findings Hemogram:"/>
  <result pre="MOF â€&quot; multi-organ failure, ARDS: Acute Respiratory Distress Syndrome, ARF-Acute" exact="Renal" post="Failure. 5 Laboratory findings Hemogram: leukopenia especially lymphopenia (in"/>
  <result pre="Respiratory Distress Syndrome, ARF-Acute Renal Failure. 5 Laboratory findings Hemogram:" exact="leukopenia" post="especially lymphopenia (in 80% of cases), mild thrombocytopenia. However,"/>
  <result pre="Syndrome, ARF-Acute Renal Failure. 5 Laboratory findings Hemogram: leukopenia especially" exact="lymphopenia" post="(in 80% of cases), mild thrombocytopenia. However, leukocytosis has"/>
  <result pre="as threshold for progression to severe illness in COVID-19 patients." exact="Inflammatory" post="Markers: serum procalcitonin is normal initially, may increase with"/>
  <result pre="is normal initially, may increase with severity. Increase in C-Reactive" exact="Protein" post="(CRP), lactate dehydrogenase (LDH), SGOT, troponin (rule out non"/>
  <result pre="CRP may be used to track the severity of disease." exact="Severe" post="and critically ill patients may have very high levels"/>
  <result pre="levels of other inflammatory markers, interleukin (IL)-6, IL-4, IL-10, and" exact="tumor" post="necrosis factor (TNF)-Î±. Poor laboratory prognostic factors include high"/>
  <result pre="investigations Hemogram, CRP, Troponin, ferritin, D-dimer, creatinine, Liver function tests" exact="Inflammatory" post="Markers CRP, Interleukins:IL-6, IL-4, IL-10, and tumor necrosis factor"/>
  <result pre="Liver function tests Inflammatory Markers CRP, Interleukins:IL-6, IL-4, IL-10, and" exact="tumor" post="necrosis factor (TNF)-Î±. Poor laboratory prognostic factors High D-Dimer,"/>
  <result pre="factors High D-Dimer, ferritin and CRP; neutrophil-to-lymphocyte ratio â‰¥3.13, lymphopenia," exact="thrombocytopenia" post="Non-ischemic causes of troponin positivity VT, SVT, AF, myocarditis,"/>
  <result pre="in specimen, heterophile antibodies. AF-Atrial fibrillation, VT-ventricular tachycardia, SVT- Supra" exact="ventricular tachycardia," post="CRP- C-reactive protein, AF- Atrial fibrillation. Serology: Blood sampling"/>
  <result pre="Supra ventricular tachycardia, CRP- C-reactive protein, AF- Atrial fibrillation. Serology:" exact="Blood" post="sampling is much easier than swab sampling from oropharynx"/>
  <result pre="proteins of SARS-CoV-2 [16,26]. Cross reactivity is expected with SARS-CoV-1" exact="infection" post="since there is 90% homology in genetic sequence with"/>
  <result pre="6 andÂ 27]. For RT-PCR, specimen collection from the upper/lower" exact="respiratory" post="tract or sputum or bronchoalveolar lavage samples to be"/>
  <result pre="to 2 days for reporting and second sample with different" exact="viral" post="gene may be needed if initial test is negative."/>
  <result pre="RT-PCR may be false negative at a times e.g. low" exact="viral" post="load in very early phase or in late phase"/>
  <result pre="samples. Similarly, result may be false-positive in influenza or other" exact="respiratory" post="pathogens. In either case it is important to remain"/>
  <result pre="a either a IgM- or IgG-ELISA test alone. b. all" exact="symptomatic" post="subjects or contacts should be assessed with rapid antibody"/>
  <result pre="cannot be obtained to rule out alternative diagnosis such as" exact="tuberculosis" post="and other bacterial or fungal pneumonias and to remove"/>
  <result pre="to rule out alternative diagnosis such as tuberculosis and other" exact="bacterial" post="or fungal pneumonias and to remove bronchial mucous plugs."/>
  <result pre="63 Fibro-bronchoscope brush biopsy 46 Pharyngeal swabs 32 Feces 29" exact="Blood" post="1 Urine 0 6 Radiology Radiological examination includes Chest"/>
  <result pre="lung sonography, done on a case to case basis. Avoid" exact="pulmonary" post="function test as chances of droplet infection may be"/>
  <result pre="case basis. Avoid pulmonary function test as chances of droplet" exact="infection" post="may be high. CXR findings are non-specific, normal in"/>
  <result pre="CXR findings are non-specific, normal in initial phases to patchy" exact="unilateral" post="or bilateral involvement to lobar/multi-lobar/bilateral consolidation [30]. The CT"/>
  <result pre="are non-specific, normal in initial phases to patchy unilateral or" exact="bilateral" post="involvement to lobar/multi-lobar/bilateral consolidation [30]. The CT changes are"/>
  <result pre="of ground glass opacities (GGO) in sub-pleural distribution involving mainly" exact="lower" post="lobes. b. Progressive stage of multi-lobe distribution with GGO,"/>
  <result pre="opacities (GGO) in sub-pleural distribution involving mainly lower lobes. b." exact="Progressive" post="stage of multi-lobe distribution with GGO, bilateral consolidation of"/>
  <result pre="lower lobes. b. Progressive stage of multi-lobe distribution with GGO," exact="bilateral" post="consolidation of airspaces (Fig.Â 1 ). c. Peak stage"/>
  <result pre="movement of patient to different department. There can be irregular" exact="pleural" post="lines, consolidation of sub-pleural areas, areas of white lung"/>
  <result pre="Moderna (a unit of the National Institute of Allergy and" exact="Infectious" post="Diseases) in USA. The trial began on 16 March"/>
  <result pre="Kaiser Permanente Washington Health Research Institute in Seattle, Washington in" exact="total" post="of 45 males and females aged between 18 and"/>
  <result pre="Remdesivir, Favipiravir, Oseltamivir, Ribavirin, Interferon beta, Tocilizumab and Abidol [32]." exact="Multiple" post="RCTs are currently undergoing with these agents and results"/>
  <result pre="and results are eagerly awaited. 8 Conclusions SARS-CoV-2 is more" exact="infectious" post="than SARS-CoV-1 and MERS-CoV. Most infections with COVID-19 are"/>
  <result pre="Conclusions SARS-CoV-2 is more infectious than SARS-CoV-1 and MERS-CoV. Most" exact="infections" post="with COVID-19 are generally mild and self-limiting. However, even"/>
  <result pre="novel coronavirus: implications for virus origins and receptor bindingLancet2020 5ZhouP.Y.XWangX.G.HuB.ZhangL.ZhangW.AÂ" exact="pneumonia" post="outbreak associated with a new coronavirus of probable bat"/>
  <result pre="Rev,. 13ZhouP.Y.X.-LWangX.-G.HuB.ZhangL.ZhangW.Discovery of a novel coronavirus associated with the recent" exact="pneumonia" post="outbreak in humans and its potential bat origin2020bioRxiv 14LiQ.Early"/>
  <result pre="J Med2020 15Bauch CtL.-S.J.CoffeeM.P.GalvaniA.P.Dynamically modeling SARS and other newly emerging" exact="respiratory" post="illnesses: past, present, and futureEpidemiology166200579180116222170 16WangYixuanUnique epidemiological and clinical"/>
  <result pre="epidemiological and clinical features of the emerging 2019 novel coronavirus" exact="pneumonia" post="(COVID-19) implicate special control measures2020 17LaiC.C.Asymptomatic carrier state, acute"/>
  <result pre="coronavirus pneumonia (COVID-19) implicate special control measures2020 17LaiC.C.Asymptomatic carrier state," exact="acute" post="respiratory disease, and pneumonia due to severe acute respiratory"/>
  <result pre="pneumonia (COVID-19) implicate special control measures2020 17LaiC.C.Asymptomatic carrier state, acute" exact="respiratory" post="disease, and pneumonia due to severe acute respiratory syndrome"/>
  <result pre="special control measures2020 17LaiC.C.Asymptomatic carrier state, acute respiratory disease, and" exact="pneumonia" post="due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2):"/>
  <result pre="carrier state, acute respiratory disease, and pneumonia due to severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2): facts and mythsJÂ Microbiol"/>
  <result pre="state, acute respiratory disease, and pneumonia due to severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2): facts and mythsJÂ Microbiol Immunol"/>
  <result pre="acute respiratory disease, and pneumonia due to severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2): facts and mythsJÂ Microbiol Immunol Infect2020"/>
  <result pre="facts and mythsJÂ Microbiol Immunol Infect2020 18ChengS.-C.First case of coronavirus" exact="disease" post="2019 (COVID-19) pneumonia in TaiwanJÂ Formos Med Assoc1193202074775132113824 19ZhaoS.L.QRanJ.Preliminary"/>
  <result pre="Microbiol Immunol Infect2020 18ChengS.-C.First case of coronavirus disease 2019 (COVID-19)" exact="pneumonia" post="in TaiwanJÂ Formos Med Assoc1193202074775132113824 19ZhaoS.L.QRanJ.Preliminary estimation of the"/>
  <result pre="the National Health Commission ofChina. 22DsH.Epidemic and emerging coronaviruses (severe" exact="acute" post="re-spiratory syndrome and Middle East respiratory syndrome)Clin Chest Med3812017718628159163"/>
  <result pre="Health Commission ofChina. 22DsH.Epidemic and emerging coronaviruses (severe acute re-spiratory" exact="syndrome" post="and Middle East respiratory syndrome)Clin Chest Med3812017718628159163 23JC.Pathogenicity and"/>
  <result pre="and emerging coronaviruses (severe acute re-spiratory syndrome and Middle East" exact="respiratory" post="syndrome)Clin Chest Med3812017718628159163 23JC.Pathogenicity and transmissibility of 2019-nCoVâ€&quot;a quickoverview"/>
  <result pre="other emerging virusesMicrobes In-fect.2020 24TanindiA.CemriM.Troponin elevation in conditions other than" exact="acute" post="coronary syndromesVasc Health Risk Manag7201159760322102783 25Xiang J, Yan M,"/>
  <result pre="for detection of novel coronavirus (SARS-Cov-2) causing an outbreak of" exact="pneumonia" post="(COVID-19). doi: 10.1101/2020.02.27.20028787. 26LiZ.YiY.LuoX.XiongN.LiuY.LiS.Development and clinical application of A"/>
  <result pre="application of A rapid IgM-IgG combined antibody test for SARS-CoV-2" exact="infection" post="diagnosisJÂ Med Virol2020 Feb 2710.1002/jmv.25727[Epub ahead of print] 27Guo"/>
  <result pre="etÂ al. Profiling early humoral response to diagnose novel coronavirus" exact="disease" post="(COVID-19), Clin Infect Dis, , ciaa310, 10.1093/cid/ciaa310. 28GaoX.ZhouH.WuC.Antibody against"/>
  <result pre="Infect Dis, , ciaa310, 10.1093/cid/ciaa310. 28GaoX.ZhouH.WuC.Antibody against nucleocapsid protein predicts" exact="susceptibility to" post="human coronavirus infectionJÂ Infect715201559960226165609 29WangW.XuYGao R.Detection of SARS-CoV-2 in"/>
  <result pre="online March 11, 2020 30PanF.Y.TianheSunPengGuiShanLiangBoLiLingliZhengDandanWangJiazhengHeskethRichardYangLianZhengC.Time course of lung changes on" exact="chest" post="CT during recovery from 2019 novel coronavirus (COVID-19) pneumoniaRadiology7782020115"/>
  <result pre="coronavirus (COVID-19) pneumoniaRadiology7782020115 31ShiH.H.X.JiangN.CaoY.AlwalidO.GuJ.Radiological findings from 81 patients with COVID-19" exact="pneumonia" post="in Wuhan, China: a descriptive studyLancet Infect Dis3099202020110 32SinghA.K.SinghA.SaikhA.SinghR.MisraA.Chloroquine"/>
 </snippets>
</snippetsTree>
